Regenxbio RGNX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$290.01M-83.9% | -$193.88M+14.6% | -$177.92M+25.5% | -$175.57M+27.2% | -$157.69M+39.4% | ||
| $15.52M-3.0% | $15.62M-3.7% | $15.77M-4.6% | $15.84M-6.5% | $15.99M-7.7% | ||
| $34.64M-7.4% | $34.56M-10.1% | $35.73M-4.1% | $36.62M-2.6% | $37.4M-3.3% | ||
| -$233.78M-178% | -$123.96M+28.4% | -$103.3M+43.3% | -$87.89M+54.0% | -$84.04M+56.4% | ||
| $2.63M-9.6% | $2.41M-0.9% | $2.99M+20.2% | $2.82M-21.6% | $2.9M-49.1% | ||
| —— | —— | —— | -$5.16M-106% | $135.27M-4.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$236.4M-172% | -$126.38M+28.0% | -$106.28M+42.5% | -$90.71M+53.4% | -$86.94M+56.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Regenxbio generate?
- Regenxbio (RGNX) generated -$233.8M in operating cash flow over the trailing twelve months.
- What is Regenxbio's free cash flow?
- After $2.6M of capital expenditures, Regenxbio's free cash flow was -$236.4M over the trailing twelve months, down 171.9% year over year.
- Where does Regenxbio's cash flow data come from?
- Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
